» Articles » PMID: 2065071

Specific Binding of Glycyrrhetinic Acid to the Rat Liver Membrane

Overview
Specialties Biochemistry
Biophysics
Date 1991 Jul 1
PMID 2065071
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

Glycyrrhetinic acid bound specifically to a particulate fraction of rat liver. The binding was dependent on time, temperature and pH, equilibrium being reached after 10 min at 37 degrees C. The equilibrium dissociation constant and the maximal concentration of the binding site, as determined by Scatchard plot analysis, were 31 nM and 43 pmol/mg protein, respectively, indicating a single binding site entity. The binding site was highly specific for glycyrrhetinic acid, glycyrrhizin, various steroids, various fatty acids and retinoids showing no or only very low affinity. The binding was inhibited by boiling or treatment with trypsin or phospholipases. The specific activity of glycyrrhetinic acid binding was the highest in the liver, followed by in the kidney. The results suggest that glycyrrhetinic acid plays a significant role in the rat liver through its specific binding protein.

Citing Articles

Recent advances of novel targeted drug delivery systems based on natural medicine monomers against hepatocellular carcinoma.

Ji G, Li Y, Zhang Z, Li H, Sun P Heliyon. 2024; 10(2):e24667.

PMID: 38312669 PMC: 10834828. DOI: 10.1016/j.heliyon.2024.e24667.


Evaluation of the liver targeting and anti‑liver cancer activity of artesunate‑loaded and glycyrrhetinic acid‑coated nanoparticles.

Pan X, Huang J, Liu S, Shao Y, Xi J, He R Exp Ther Med. 2023; 26(5):516.

PMID: 37854499 PMC: 10580252. DOI: 10.3892/etm.2023.12215.


Glycyrrhizic Acid and Its Derivatives: Promising Candidates for the Management of Type 2 Diabetes Mellitus and Its Complications.

Tan D, Tseng H, Zhong Z, Wang S, Vong C, Wang Y Int J Mol Sci. 2022; 23(19).

PMID: 36232291 PMC: 9569462. DOI: 10.3390/ijms231910988.


Recent Advances in Glycyrrhetinic Acid-Functionalized Biomaterials for Liver Cancer-Targeting Therapy.

Speciale A, Muscara C, Molonia M, Cristani M, Cimino F, Saija A Molecules. 2022; 27(6).

PMID: 35335138 PMC: 8954912. DOI: 10.3390/molecules27061775.


Glycyrrhizic Acid and Its Hydrolyzed Metabolite 18β-Glycyrrhetinic Acid as Specific Ligands for Targeting Nanosystems in the Treatment of Liver Cancer.

Stecanella L, Bitencourt A, Vaz G, Quarta E, Silva Junior J, Rossi A Pharmaceutics. 2021; 13(11).

PMID: 34834206 PMC: 8621092. DOI: 10.3390/pharmaceutics13111792.